1,1'-Bis(2,4-dinitrophenyl)-4,4'-bipyridinium dichloride, 98%, 5g

SULFAQUINOXALINE, 96%, 250mg

6-HYDROXY-3-PYRIDAZINECARBOXYLIC ACID MONOHYDRATE, 97.0%, 1g

6-Hydroxyimidazo[1,2-b]pyridazine, 95.0%, 10g

(3R)-3-[4-(Trifluoromethyl)phenyl]morpholine, 98%, 250mg

5-chloro-2-isobutoxybenzaldehyde, 95.0%, 5g

2-(((4H-1,2,4-triazol-3-yl)thio)methyl)benzoic acid, 250mg

p-Tolyl Crotonate>55.0%(GC)25mL

4-Bromo-1-(1-methylcyclopropyl)-1H-pyrazole, 98%, 250mg

Ethyl 5-amino-1-(4-nitrophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

Spiro[3.4]Octan-1-ol, 98%, 1g

Recipiente di reazione a flangia piatta cilindrico, graduato (2) Fondo piatto, DN 150, 160 mm, Altezza, 325 mm, 1 Pezzo

2-(Chloromethyl)-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-amine, 98%, 100mg